Stay updated on Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.

Latest updates to the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, indicating a minor internal update to the page's documentation.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page footer revision indicator was updated to v3.5.4 to reflect the latest site build.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page revision label was updated from “v3.5.2” to “v3.5.3,” reflecting a minor change to the ClinicalTrials.gov site version rather than the content of the study record.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page. This is a minor site version update with no changes to study information or user-facing functionality.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded a PubMed-listed publication about TAK-981 and a note that publications are auto-filled from PubMed.SummaryDifference0.2%

- Check80 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

Stay in the know with updates to Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Intratumoral TAK-981 Microdosing in Head and Neck Cancer Clinical Trial page.